Literature DB >> 14561737

Differential processing of CD4 T-cell epitopes from the protective antigen of Bacillus anthracis.

Julie A Musson1, Nicola Walker, Helen Flick-Smith, E Diane Williamson, John H Robinson.   

Abstract

We have mapped CD4+ T-cell epitopes located in three domains of the recombinant protective antigen of Bacillus anthracis. Mouse T-cell hybridomas specific for these epitopes were generated to study the mechanisms of proteolytic processing of recombinant protective antigen for antigen presentation by bone marrow-derived macrophages. Overall, epitopes differed considerably in their processing requirements. In particular, the kinetics of presentation, ranging from 15 (fast) to 120 min (slow), suggested sequential liberation of epitopes during proteolytic processing of the intact PA molecule. Pretreatment of macrophages with ammonium chloride or inhibitors of the major enzyme families showed that T-cell responses to an epitope presented with fast kinetics were unaffected by raising endosomal pH or inhibiting cysteine or aspartic proteinases, suggesting presentation independent of lysosomal processing. In contrast, responses to epitopes presented with slower kinetics were dependent on low pH and the activity of cysteine or aspartic proteinases indicating a requirement for lysosomal processing. In addition, responses to all epitopes, whether their presentation was dependent on low pH or not, were prevented by treatment of macrophages with broad spectrum serine proteinase inhibitors. Thus, our data are consistent with a model of sequential antigen processing within the endosomal system, beginning with a pre-processing step mediated by serine or metalloproteinases prior to further processing by lysosomal enzymes. Rapidly presented epitopes seemed to require only limited proteolysis at earlier stages of endocytosis, whereas the majority of epitopes required more extensive processing by neutral proteinases followed by lysosomal enzymes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561737     DOI: 10.1074/jbc.M309034200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.

Authors:  E D Williamson; I Hodgson; N J Walker; A W Topping; M G Duchars; J M Mott; J Estep; C Lebutt; H C Flick-Smith; H E Jones; H Li; C P Quinn
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Major histocompatibility class II molecules prevent destructive processing of exogenous peptides at the cell surface of macrophages for presentation to CD4 T cells.

Authors:  Alexei von Delwig; Julie A Musson; Joe Gray; Norman McKie; John H Robinson
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

3.  Characterization of a permissive epitope insertion site in adenovirus hexon.

Authors:  Michael J McConnell; Xavier Danthinne; Michael J Imperiale
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis.

Authors:  Ho-Ki Shim; Julie A Musson; Helen M Harper; Hesta V McNeill; Nicola Walker; Helen Flick-Smith; Alexei von Delwig; E Diane Williamson; John H Robinson
Journal:  Immunology       Date:  2006-08-18       Impact factor: 7.397

5.  Immunogenicity of a Yersinia pestis vaccine antigen monomerized by circular permutation.

Authors:  David A Chalton; Julie A Musson; Helen Flick-Smith; Nicola Walker; Alistair McGregor; Heather K Lamb; E Diane Williamson; Julie Miller; John H Robinson; Jeremy H Lakey
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

6.  Immunodominance of CD4 T cells to foreign antigens is peptide intrinsic and independent of molecular context: implications for vaccine design.

Authors:  Jason M Weaver; Christopher A Lazarski; Katherine A Richards; Francisco A Chaves; Scott A Jenks; Paula R Menges; Andrea J Sant
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

7.  Activation of human CD4+ T cells by targeting MHC class II epitopes to endosomal compartments using human CD1 tail sequences.

Authors:  Kayvan R Niazi; Maria-Teresa Ochoa; Peter A Sieling; Nanette E Rooke; Anna K Peter; Pamela Mollahan; Micah Dickey; Shahrooz Rabizadeh; Thomas H Rea; Robert L Modlin
Journal:  Immunology       Date:  2007-07-16       Impact factor: 7.397

8.  Asymptomatic HIV-infected individuals on antiretroviral therapy exhibit impaired lung CD4(+) T-cell responses to mycobacteria.

Authors:  Kondwani C Jambo; Dominic H Banda; Louise Afran; Anstead M Kankwatira; Rose D Malamba; Theresa J Allain; Stephen B Gordon; Robert S Heyderman; David G Russell; Henry C Mwandumba
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 21.405

Review 9.  Thymus-specific serine protease, a protease that shapes the CD4 T cell repertoire.

Authors:  Sylvie Guerder; Chervin Hassel; Alice Carrier
Journal:  Immunogenetics       Date:  2018-09-17       Impact factor: 2.846

Review 10.  Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum.

Authors:  Laura M Zarebski; Kerrie Vaughan; John Sidney; Bjoern Peters; Howard Grey; Kim D Janda; Arturo Casadevall; Alessandro Sette
Journal:  Expert Rev Vaccines       Date:  2008-02       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.